These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3590064)
1. [Orphan drugs: what are they and why do they not find adoptive parents?]. Lechat P Therapie; 1987; 42(1):33-6. PubMed ID: 3590064 [No Abstract] [Full Text] [Related]
3. Orphan drug development in the United States. Groft SC CPJ; 1985 May; 118(5):219-22. PubMed ID: 10271306 [TBL] [Abstract][Full Text] [Related]
4. [Orphan drugs in France (2001-2005): access to information and characteristics]. Baumevieille M; Daveluy A; Aulois-Griot M; Haramburu F Therapie; 2007; 62(1):9-16. PubMed ID: 17374342 [TBL] [Abstract][Full Text] [Related]
5. Orphan Drug Act on congressional agenda. von Oehsen WH Physician Exec; 1989; 15(3):34-5. PubMed ID: 10313123 [TBL] [Abstract][Full Text] [Related]
6. Orphan Drugs Information Center. FDA Drug Bull; 1985 Apr; 15(1):9-10. PubMed ID: 3996806 [No Abstract] [Full Text] [Related]
7. The development of orphan drugs--a pharmaceutical company perspective. Stucki JC Prog Clin Biol Res; 1985; 197():95-104. PubMed ID: 4070303 [No Abstract] [Full Text] [Related]
8. Orphan drugs: the question of products liability. Scharf SF Am J Law Med; 1985; 10(4):491-513. PubMed ID: 3911776 [TBL] [Abstract][Full Text] [Related]
10. [Orphan drugs--competing for a better name in Sweden]. Karlsson Y Lakartidningen; 1990 Feb; 87(9):658. PubMed ID: 2308437 [No Abstract] [Full Text] [Related]
12. Problems associated with developing orphan drugs into available therapy. Van Woert MH Prog Clin Biol Res; 1985; 197():171-3. PubMed ID: 4070291 [No Abstract] [Full Text] [Related]
13. Cooperative approaches to research and development of orphan drugs. Proceedings of a conference. New York, New York, April 9 and 10, 1984. Prog Clin Biol Res; 1985; 197():1-204. PubMed ID: 4070283 [No Abstract] [Full Text] [Related]
14. [Orphan drugs]. Kolár J; Chalabala M; Srámková H Ceska Slov Farm; 2001 Mar; 50(2):59-65. PubMed ID: 11288591 [TBL] [Abstract][Full Text] [Related]
15. The role of voluntary disease organizations in research and development of orphan drugs. Horansky R Prog Clin Biol Res; 1985; 197():179-81. PubMed ID: 4070293 [No Abstract] [Full Text] [Related]
16. The fuel to run the orphan drug engine: a medical school-based Orphan Disease Center Program. Brewer GJ Prog Clin Biol Res; 1985; 197():123-38. PubMed ID: 4070287 [No Abstract] [Full Text] [Related]
17. Generic Pharmaceutical Industry Association Orphan Drug Institute. Haddad W Prog Clin Biol Res; 1985; 197():41-5. PubMed ID: 4070298 [No Abstract] [Full Text] [Related]
18. Understanding orphan drug regulations: an EU and U.S. comparative analysis. Grienenberger A J Biolaw Bus; 2004; 7(3):58-61. PubMed ID: 15460604 [TBL] [Abstract][Full Text] [Related]